NeoGenomics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NeoGenomics and other ETFs, options, and stocks.About NEO
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T.
CEOAnthony P. Zook
CEOAnthony P. Zook
Employees2,200
Employees2,200
HeadquartersFort Myers, Florida
HeadquartersFort Myers, Florida
Founded1998
Founded1998
Employees2,200
Employees2,200
NEO Key Statistics
Market cap1.59B
Market cap1.59B
Price-Earnings ratio-13.86
Price-Earnings ratio-13.86
Dividend yield—
Dividend yield—
Average volume1.73M
Average volume1.73M
High today$12.39
High today$12.39
Low today$12.19
Low today$12.19
Open price$12.24
Open price$12.24
Volume1.15M
Volume1.15M
52 Week high$19.12
52 Week high$19.12
52 Week low$4.72
52 Week low$4.72
Stock Snapshot
With a market cap of 1.59B, NeoGenomics(NEO) trades at $12.30. The stock has a price-to-earnings ratio of -13.86.
As of 2025-12-30, NeoGenomics(NEO) stock has fluctuated between $12.19 and $12.39. The current price stands at $12.30, placing the stock +0.9% above today's low and -0.7% off the high.
NeoGenomics(NEO) shares are trading with a volume of 1.15M, against a daily average of 1.73M.
During the past year, NeoGenomics(NEO) stock moved between $4.72 at its lowest and $19.12 at its peak.
During the past year, NeoGenomics(NEO) stock moved between $4.72 at its lowest and $19.12 at its peak.
Analyst ratings
50%
of 14 ratingsBuy
42.9%
Hold
50%
Sell
7.1%
People also own
Based on the portfolios of people who own NEO. This list is generated using Robinhood data, and it’s not a recommendation.